'Your system has failed': HC to Delhi govt over black marketing of oxygen

HC directs Delhi govt to file report on number of deaths of COVID-19 patients in hospitals and nursing homes due to shortage of oxygen

Oxygen
Representational image (Photo: PTI)
Press Trust of India New Delhi
2 min read Last Updated : Apr 27 2021 | 6:41 PM IST

The Delhi High Court Tuesday directed the AAP government to check black marketing of oxygen cylinders and crucial medicines for COVID-19 patients and address the issue of oxygen distribution to hospitals as well as individuals.

It directed the Delhi government to file a report on the number of deaths of COVID-19 patients in hospitals and nursing homes due to the shortage of oxygen.

The high court also directed the government to take over the plant of an oxygen refiller for not supplying gas to hospitals and allegedly giving it in black market, and made it clear that the same action should be taken with regard to other suppliers who refuse to fall in line.

Besides, it asked the Delhi government to take account of stock and sale of medicines such as Remdesivir, Fabiflu and Tocilizumab at hospitals' pharmacies, as people are unable to get these drugs which are being sold at much higher rates in black market.

A bench of Justices Vipin Sanghi and Rekha Palli, which was hearing the case relating to oxygen crisis and shortage of medicines to treat COVID-19 patients for over three hours, said non-accounting of oxygen cylinders supplies by Delhi government was leading to artificial shortage of gas and black marketing.

The court observed it is not the time to become vultures.

Are you aware of black marketing. Is it a good human gesture, the bench said to oxygen refillers.

It also said the Delhi government's entire system has failed as black marketing of oxygen cylinders and crucial medicines for treating COVID-19 patients is going on.

The bench further said this is a mess that the state government has been unable to resolve.

You have the power, take action against those engaging in black marketing of oxygen cylinders and medicines, it said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Apr 27 2021 | 5:21 PM IST

Next Story